Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma

Fig. 3

Low expression of BCL2L13 significantly affects the prognosis of ccRCC and pRCC. AB Kaplan–Meier survival plot of ccRCC (A) and pRCC (B) that grouped by BCL2L13 mRNA levels. C Poor prognosis of ccRCC that related to the down-regulation of BCL2L13 is independent of patients’ gender (left) or tumor grade (right). Log-rank test was implemented for comparison of survival probability

Back to article page